Cargando…

Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment

Glioblastoma multiforme (GBM) is a grade IV glioma considered the most fatal cancer of the central nervous system (CNS), with less than a 5% survival rate after five years. The tumor heterogeneity, the high infiltrative behavior of its cells, and the blood–brain barrier (BBB) that limits the access...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Kheir, Wiam, Marcos, Bernard, Virgilio, Nick, Paquette, Benoit, Faucheux, Nathalie, Lauzon, Marc-Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227363/ https://www.ncbi.nlm.nih.gov/pubmed/35745762 http://dx.doi.org/10.3390/pharmaceutics14061189

Ejemplares similares

Characterization and Mathematical Modeling of Alginate/Chitosan-Based Nanoparticles Releasing the Chemokine CXCL12 to Attract Glioblastoma Cells
por: Gascon, Suzanne, et al.
Publicado: (2020)

Erratum: Gascon S.; et al. Characterization and Mathematical Modeling of Alginate/Chitosan-Based Nanoparticles Releasing the Chemokine CXCL12 to Attract Glioblastoma Cells. Pharmaceutics 2020, 12, 356
por: Gascon, Suzanne, et al.
Publicado: (2020)

Peptides derived from the knuckle epitope of BMP-9 induce the cholinergic differentiation and inactivate GSk3beta in human SH-SY5Y neuroblastoma cells
por: Lauzon, Marc-Antoine, et al.
Publicado: (2017)

Both Human Hematoma Punctured from Pelvic Fractures and Serum Increase Muscle Resident Stem Cells Response to BMP9: A Multivariate Statistical Approach
por: Alinejad, Yasaman, et al.
Publicado: (2020)

Muscle injury-induced hypoxia alters the proliferation and differentiation potentials of muscle resident stromal cells
por: Drouin, Geneviève, et al.
Publicado: (2019)

Local Drug Delivery Strategies for Glioblastoma Treatment
por: Cha, Gi Doo, et al.
Publicado: (2022)

Nanoscale Drug Delivery Systems in Glioblastoma
por: Liu, Zihao, et al.
Publicado: (2022)

Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
por: Hsu, Jen-Fu, et al.
Publicado: (2021)

Novel Drug Delivery Strategies for the Treatment of Onychomycosis
por: Dhamoon, Rupinder K., et al.
Publicado: (2019)

Novel Treatment Strategies for Glioblastoma
por: Stylli, Stanley S.
Publicado: (2020)

Novel Ion Channel Targets and Drug Delivery Tools for Controlling Glioblastoma Cell Invasiveness
por: Varricchio, Alanah, et al.
Publicado: (2021)

Microsponges: A novel strategy for drug delivery system
por: Kaity, Santanu, et al.
Publicado: (2010)

Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance
por: Mishra, Nidhi, et al.
Publicado: (2013)

Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme
por: Nam, L., et al.
Publicado: (2018)

Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
por: Lim, Xin Yuan, et al.
Publicado: (2023)

Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment
por: Belhadj, Zakia, et al.
Publicado: (2017)

Breaking barriers for glioblastoma with a path to enhanced drug delivery
por: Noorani, Imran, et al.
Publicado: (2023)

Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
por: Rabah, Nadin, et al.
Publicado: (2023)

Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
por: Bruinsmann, Franciele Aline, et al.
Publicado: (2019)

Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
por: Caffery, Breanne, et al.
Publicado: (2019)

Novel Treatment Strategies for Glioblastoma—A Summary
por: Stylli, Stanley S.
Publicado: (2021)

Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma
por: Ruiz-Garcia, Henry, et al.
Publicado: (2021)

Paclitaxel Delivery to the Brain for Glioblastoma Treatment
por: AbdEl-haq, Muhammad, et al.
Publicado: (2023)

Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature
por: Alomari, Safwan, et al.
Publicado: (2021)

Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment
por: Ellis, Jason A., et al.
Publicado: (2015)

Insights into Multifunctional Nanoparticle-Based Drug Delivery Systems for Glioblastoma Treatment
por: Khan, Mohd, et al.
Publicado: (2021)

Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme
por: Behl, Tapan, et al.
Publicado: (2021)

Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art
por: Di Filippo, Leonardo Delello, et al.
Publicado: (2021)

New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme
por: Singh, Manisha, et al.
Publicado: (2022)

Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
por: Brar, Harpinder K., et al.
Publicado: (2022)

Mouse models of glioblastoma for the evaluation of novel therapeutic strategies
por: Haddad, Alexander F, et al.
Publicado: (2021)

Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug Delivery
por: Fleten, Karianne Giller, et al.
Publicado: (2022)

Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma
por: Gao, Yixing, et al.
Publicado: (2019)

Prediction of Anti-Glioblastoma Drug-Decorated Nanoparticle Delivery Systems Using Molecular Descriptors and Machine Learning
por: Munteanu, Cristian R., et al.
Publicado: (2021)

Evaluation of Three Morphologically Distinct Virus-Like Particles as Nanocarriers for Convection-Enhanced Drug Delivery to Glioblastoma
por: Finbloom, Joel A., et al.
Publicado: (2018)

Current Strategies for Brain Drug Delivery
por: Dong, Xiaowei
Publicado: (2018)

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells
por: Burster, Timo, et al.
Publicado: (2021)

Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety
por: Guo, Yuhang, et al.
Publicado: (2022)

Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy
por: Kim, Dong Geon, et al.
Publicado: (2016)

Poly(ethylene glycol) based nanotubes for tuneable drug delivery to glioblastoma multiforme
por: Alghamdi, Majed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ok4nigihp2mvkdin1osj95kbuv